title: How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
authors.affiliation: Otto-von-Guericke-University Magdeburg, Magdeburg, Germany michael.koehler@med.ovgu.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Koehler
authors.affiliation: Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Fischer
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D011788:Quality of Life; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin